The natural polyphenol resveratrol and its analogue piceatannol have various beneficial effects including antiarrhythmic properties. The aim of the present study was to examine potential electrophysiologic effects in an experimental whole-heart model of atrial fibrillation (AF). Simultaneous infusion of resveratrol (50 μmol/L) or piceatannol (10 μmol/L) in rabbit hearts resulted in an increase in atrial refractory period.
| INTRODUC TI ON
Recently developed antiarrhythmic agents like vernakalant have been reported to have a beneficial electrophysiologic profile. 1 However, vernakalant is only marketed for acute cardioversion of recent-onset atrial fibrillation (AF). 2 Previously, dronedarone was enthusiastically expected, as initial clinical 3 and experimental data 4 suggested, to have beneficial effects. However, limited clinical efficacy compared with established substances and further experimental 5, 6 and clinical experiences 7 suggested harmful interactions with digitalis glycosides. Recurrent discussion on the 'French Paradox' directed interest to some compounds of red wine. The polyphenol resveratrol has antiinflammatory, antioxidative, antidiabetes and anticancer properties that are attributed to this compound. On the molecular level, inhibition of late I Na was observed for resveratrol. 10 A study using the wholecell voltage-clamp technique with tsA201 cells to record peak and late voltage-gated sodium channel currents (I Na ) from recombinant human heart NaV1.5 channels showed no frequency dependence of peak I Na block but of late I Na for resveratrol. 11 Antiarrhythmic effects were observed in experimental models of long-QT syndrome. 12, 13 However, no clinical study supports the hypothesis that resveratrol or low or moderate alcohol intake may be associated with a lower risk of AF. 14 Piceatannol is a derivative of resveratrol with similar effects 15 although the direct influence on sodium currents slightly differs. 16 Of note, proarrhythmic effects have been observed in failing rabbit hearts for this polyphenol. 17 The aim of the present study was to determine the electrophysiologic profile of resveratrol and piceatannol in an established whole-heart model of AF. The method of preparing the hearts and the stability of the experimental set-up has previously been described in detail. 18 The experimental protocol is described in Appendix S1.
| RE SULTS
Acute treatment with a combination of acetylcholine and isoproterenol led to an increase in intrinsic heart rate measured as a reduction in basic atrial cycle length (resveratrol group: 548 ± 165 vs.
432 ± 134 ms; piceatannol group: 448 ± 82 ms vs. 321 ± 104 ms).
This effect was reversed by resveratrol 608 ± 193 ms, P < .02) or piceatannol (452 ± 143 ms, P < .02, Figure 1 ).
Treatment with acetylcholine and isoproterenol induced a significant abbreviation of atrial action potential duration at 90% repolarization (aAPD 90 ) and atrial effective refractory period (aERP) in both groups. Both resveratrol and piceatannol prolonged atrial repolarization and refractory periods. A more marked prolongation of aERP compared with aAPD 90 led to a significant increase in atrial postrepolarization refractoriness (resveratrol: 13 ± 5 ms vs. 21 ± 8 ms, P < .05; piceatannol 17 ± 5 ms vs. 28 ± 8 ms, P < .01).
No relevant change in interatrial conduction time was monitored under the influence of acetylcholine and isoproterenol. Infusion of resveratrol significantly increased this parameter (7 ± 3 ms vs.
13 ± 5 ms, P < .01). In accordance, treatment with piceatannol also increased interatrial conduction time (8 ± 2 ms vs. 12 ± 4 ms, P < .01).
Administration of acetylcholine and isoproterenol increased the The electrophysiologic profile of the two polyphenols resveratrol and piceatannol suggests that both agents directly interact with sodium currents. The described alterations of electrophysiologic parameters resemble those of the antiarrhythmic drugs ranolazine 18 and vernakalant. 20 For these agents, a significant increase in atrial refractory period as well as a slowing of conduction have been reported. Of note, the effects exerted by resveratrol and piceatannol are less marked than those of the described antiarrhythmic agents in previous studies. Nonetheless, the results of the present study support previous investigations where antiarrhythmic properties were observed in experimental models of long-QT syndrome 12 and direct effects on sodium currents were described. The marked effect on atrial conduction may be mainly based on the inhibition of the late sodium current, as in a previously published experimental study no frequency dependence of peak I Na block was observed for resveratrol.
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Additive application of polyphenols may exert beneficial effects in the setting of AF. The observed alterations of electrophysiologic parameters resemble those of antiarrhythmic agents and most likely both polyphenols exert direct effects on sodium currents as well as the pacemaker current.
Treatment with polyphenols could have important advantages over monotherapy with established antiarrhythmic agents as they suggest a stabilization of atrial repolarization. This is of particular interest as there are no severe side effects known for both resveratrol and piceatannol.
The present study was conducted in isolated Langendorffperfused hearts. Therefore, a thorough analysis of direct drug effects on cardiac ion currents is not possible. However, the electrophysiologic profile of both drugs suggests direct effects on atrial ion currents. A significant reduction in inducibility of AF could not be proven in the present study. In particular for nonantiarrhythmic hearts, the number of hearts needed to prove a significant suppression of inducible arrhythmias is rather high.
Therefore, this small study was designed to assess potential effects of the examined polyphenols on atrial repolarization, conduction and refractory periods. Unfortunately, clinical experience on effective doses of both polyphenols is not available which limits the transfer to the clinical setting. Furthermore, only single concentrations for both polyphenols were employed. However, the dosage was derived from a previous study where detailed dose-response experiments on ventricular repolarization were performed.
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The present study suggests that both resveratrol and piceatannol exert direct effects on atrial electrophysiology. An increase in atrial refractory period and a slowing of conduction were observed.
Consequently, resveratrol and piceatannol seem to stabilize atrial repolarization and may be further investigated as a potential option for additive antiarrhythmic therapy for AF.
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